Suppression of experimental autoimmune encephalomyelitis with a TNF binding protein (TNFbp) correlates with down-regulation of VCAM-1/VLA-4

European Journal of Immunology

Volumn 28, Issue 6, 1998, Pages 2035-2044

  Selmaj, Krzysztof ^a,b   Walczak, Agata ^a   Mycko, Marcin ^a   Berkowicz, Tomasz ^a   Kohno, Tadahiko ^c   Raine, Cedric S ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c AMGEN INC   (United States)

Author keywords

Adhesion molecule; Experimental autoimmune encephalomyelitis; TNF binding protein

Indexed keywords

BETA1 INTEGRIN; L SELECTIN; MYELIN BASIC PROTEIN; TUMOR NECROSIS FACTOR BINDING PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; IMMUNOCHEMISTRY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD;

ANIMALS; CARRIER PROTEINS; CD4-CD8 RATIO; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNOPHENOTYPING; INTEGRIN ALPHA4BETA1; INTEGRINS; INTERCELLULAR ADHESION MOLECULE-1; L-SELECTIN; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; RECEPTORS, LYMPHOCYTE HOMING; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SPLEEN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031813901     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199806)28:06<2035::AID-IMMU2035>3.0.CO;2-A     Document Type: Article

References (46)

1. Raine, C. S., Multiple sclerosis: TNF revisited, with promise. Nature Med. 1995. 1: 211-214.
2. Selmaj, K., Raine, C. S., Cannella, B. and Brosnan, C. F., Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 1991. 87: 949-954.
3. Raine, C. S. and Cannella, B., Adhesion molecules and central nervous system inflammation. Semin. Neurosci. 1993. 4: 201-220.
4. Cannella, B. and Raine, C. S., The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 1995. 37: 424-435.
5. Sharief, M. K., Phil, M. and Hentges, R., Association between tumor necrosis factor and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 1991. 325: 467-476.
6. Powell, M. B., Mitchell, D., Lederman, J., Buchmeier, J., Zamvil, S. S., Graham, M., Ruddle, N. H. and Steinman, L., Lymphotoxin production by myelin basic protein specific T cell clones correlates with encephalitogenicity. Int. Immunol. 1990. 2: 539-551.
7. Ruddle, N. H., Jergman, Ch. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J. and Clark, R. B., An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 1990. 172: 1193-1202.
8. Selmaj, K., Raine, C. S. and Cross, A. H., Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 1991. 30: 694-700.
9. Sommer, N., Loschmann, P.-A., Northoff, G. H., Weller, M., Steinbrecher, A., Steinbach, J. P., Lichtenfels, R., Meyermann, R., Riethmuller, A., Fontana, A., Dichgans, J. and Martin, R., The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Med. 1995. 1: 244-248.
10. Genain, C. P., Roberts, T., Davis, R. L., Nguyen, M.-H., Uccelli, A., Faulds, D., Li, Y., Hedgpeth, J. and Hauser S. L., Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. USA 1995. 92: 3601-3605.
11. Baker, D., Butler, D., Scallon, B. J., O'Neil, J. K., Turk, J. L. and Feldman, M., Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 1994. 24: 2040-2048.
12. Selmaj, K., Papierz, W., Glabinski, A. and Kohno, T., Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor 1. J. Neuroimmunol. 1995. 56: 135-141. J. Exp. Med. 1989. 170: 1671-1680.
13. Selmaj, K., Papierz, W., Glabinski, A. and Kohno, T., Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor 1. J. Neuroimmunol. 1995. 56: 135-141. J. Exp. Med. 1989. 170: 1671-1680.
14. Martin, D., Near, S. J., Bendele, A. and Russell, D. A., Inhibition of tumor necrosis factor is protective against neurologic disfunction after active immunization of Lewis rats with myelin basic protein. Exp. Neurol. 1995. 131: 221-228.
15. Klinkert, W. E. F., Kojima, K., Lesslauer, W., Rinner, W., Lassmann, H. and Wekerle, H., TNF-α receptor fusion protein prevents experimental autoimmune encephalomyelitis and demyelination in Lewis rats: an overview. J. Neuroimmunol. 1997. 72: 163-168.
16. Yokota, S., Geppert, T. D. and Lipsky, P. I., Enhancement of antigen-and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor. J. Immunol. 1988. 140: 531-543.
17. Ranges, G. E., Figari, I. S., Espevik, T. and Palladino, M. A., Inhibition of cytotoxic T cell development by transforming growth factor-beta and reversal by recombinant tumor necrosis factor alpha. J. Exp. Med. 1987. 166: 991-1001.
18. Arbones, M. L., Ord, D. C., Ley, K., Ratech, H., Maynard-Curry, C., Otten, G., Capon, D. J. and Tedder, T. F., Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1994. 1: 247-260.
19. Imhof, B. A. and Dunon, D., Leukocyte migration and adhesion. Adv. Immunol. 1995. 58: 345-416.
20. Sobel, R. A., Mitchell, M. E. and Fondren, G., Intracellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am. J. Pathol. 1990. 136: 1309-1316.
21. Cannella, B., Cross, A. H. and Raine, C. S., Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J. Exp. Med. 1990. 172: 1521-1524.
22. Cannella, B., Cross, A. H. and Raine, C. S., Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 1993. 46: 43-55.
23. Archelos, J. J., Jung, S., Maurer, M., Schmied, M., Lassmann, H., Tamtani, T., Miyasaka, M., Toyka, K. V. and Hartung, H.-P., Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann. Neurol. 1993. 34: 145-154.
24. Welsh, C. T., Rose, J. W., Hill, K. E. and Townsend, J. J., Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1. J. Neuroimmunol. 1993. 43: 161-168.
25. Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L. and Karin, N., Prevention of experimental autoimmune encephalomyelitis by antibodies against a4b1 integrin. Nature 1993. 356: 63-66.
26. Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G. and Janeway, C. A., Surface expression of a4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 1993. 177: 57-68.
27. Cavender, D. E., Edelbaum, D. and Ziff, M., Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am. J. Physiol. 1989. 134: 551-563.
28. Barten, D. M. and Ruddle, N. H., Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J. Neuroimmunol. 1994. 51: 123-133.
29. Hale, K. K., Smith, C. G., Baker, S. L., Vanderslice, R. W., Squires, C. H., Gleasson, T. M., Tucker, K. K., Kohno, T. and Russell, D. A., Multifunctional regulation of the biological effects of TNFa by the soluble type I and type 11 TNF receptors. Cytokine 1995. 7: 26-38.
30. Frei, K., Eugster, H.-P., Bobst, M., Constantinescu, C. S., Lavi, E. and Fontana, A., Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 1997. 12: 2177-2182.
31. Steinman, L., Some misconceptions about understanding autoimmunity through experiments with knockouts. J. Exp. Med. 1997. 12: 2039-2041.
32. Kundig, T. M., Schorle, H., Bachmann, M. F., Hengartner, H., Zinkernagel, R. M. and Horak, I., Immune responces in interleukin-2-deficient mice. Science 1993. 262: 1059-1061.
33. Korner, H., Riminton, D. S., Strickland, D. H., Lemckert, F. A., Pollard, J. D. and Sedgwick, J. D., Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med. 1997. 186: 1585-1590.
34. Suen, W. E., Bergman, C. M., Hjelstrom; P. and Ruddle, N. H., A critical role for lymphotoxin in experimental autoimmune encephalomyelitis. J. Exp. Med. 1997. 186: 1233-1240.
35. Sedgwick, J., Brostoff, S. and Mason, D., Experimental allergic encephalomyelitis in the absence of classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin-2 receptor-positive cells infiltrating the central nervous system. J. Exp. Med. 1987. 165: 1058-1063.
36. Brightman, B. K. and Fan, H., The CD4 surface antigen is induced and maintained on T-lymphoid cell line by tumor necrosis factor-alpha. Lymphokine. Cytokine. Res. 1993. 12: 293-302.
37. Pettinelli, C. B. and McFarlin, D. E., Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+2+ T lymphocytes. J. Immunol. 1982. 127: 1420-1430.
38. Evans, S. S., Coller, R. P., Appenheimer, M. M. and Gollick, S., Interferon-α induces the expression of the L-selectin homing receptor in human B lymphoid cells. J. Cell. Biol. 1993. 123: 1889-1898.
39. Rothlein, R., Czajkowski, W., O'Neil, M. M., Marlin, S. D., Mainolki, E. and Merkuzzi, M. J., Induction of cellular adhesion molecule-1 on primary and continuous cell lines by proinflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. J. Immunol. 1988. 141: 1665-1669.
40. Korner, H., Goodsall, A. L., Lemckert, F. A., Scallon, B. J., Ghrayeb, J., Ford, A. L. and Sedgwick, J. D., Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 1995. 92: 11066-11070.
41. Korner, H., Lemckert, F. A., Chaudhri, G., Etteldorf, S. and Sedgwick, J. D., Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system. Eur. J. Immunol. 1997. 27: 1973-1981.
42. Evans, T. J., Moyes, D., Carpenter, A., Martin, R., Loetscher, H., Lesslauer, W. and Cohen, W. J., Protective effect of 55kD but not 75kD soluble TNF receptor-IgG fusion proteins in an animal model of Gram negative sepsis. J. Exp. Med. 1994. 180: 2173-2179.
43. Fernandez-Botran, R., Chilton, P. M. and Ma, Y., Soluble cytokine receptors: Their roles in immunoregulation, disease, and therapy. Adv. Immunol. 1996. 63: 269-336.
44. Mohler, K. M., Torrance, D. J., Smith, C. A., Goodwin, R. G., Stremler, K. E., Fung, V. P., Madini, H. and Widmer, M. B. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 1993. 151: 1548-1561.
45. van Zee, K. J., Kohno, T., Fischer, E., Rock, C. S., Moldawer, L. L. and Lower, S. F., Tumor necrosis factor receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc. Natl. Acad. Sci. USA 1992. 89: 4845-4850.
46. Moore, G. R. W., Traugott, U., Farooq, M., Norton, W. T. and Raine, C. S., Experimental autoimmune encephalomyelitis: augmentation of demyelination by different myelin lipids. Lab. Invest. 1984. 51: 416-428.